tradingkey.logo
tradingkey.logo
Search

Rani Therapeutics Holdings Inc

RANI
Add to Watchlist
0.774USD
-0.046-5.63%
Close 07-31 16:00ETQuotes delayed by 15 min
77.27MMarket Cap
LossP/E TTM

RANI Financials

See Rani Therapeutics Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Rani Therapeutics Holdings Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.04/-0.05
Revenue / Forecast
1.71M/500.00K
Period
FY2025 Earnings
Revenue(YoY)
1.63M
58.85%
EPS(YoY)
-0.45
57.44%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
82.01%-0.04
74.55%-0.07
50.46%-0.12
29.16%-0.18
24.43%-0.22
0.22%-0.27
34.65%-0.24
29.57%-0.26
13.35%-0.29
22.20%-0.27
---0.36
---0.37
---0.33
---0.35
---0.93
----
----
----
----
----
Revenue
893.02%1.71M
42.12%1.46M
--0.00
--0.00
--172.00K
--1.03M
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
3168.33%1.96M
Net Profit
3.18%-7.03M
-15.18%-10.30M
20.21%-5.41M
1.66%-6.69M
2.93%-7.26M
-26.05%-8.95M
26.25%-6.78M
26.85%-6.80M
10.62%-7.48M
19.21%-7.10M
-15.61%-9.20M
-22.02%-9.30M
-34.53%-8.37M
-69.32%-8.79M
-153.18%-7.96M
-39.00%-7.62M
-11.16%-6.22M
9.85%-5.19M
-8.98%-3.14M
-102.10%-5.49M
Net Margin
93.66%-469.26%
59.39%-621.08%
----
----
---7405.81%
---1529.38%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
----
----
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
-100.00%0.00%
105.38%133.51%
51.14%101.96%
57.63%86.72%
32.44%67.19%
56.16%65.01%
92.49%67.46%
81.66%55.01%
88.01%50.73%
--41.63%
--35.04%
--30.28%
--26.98%
--13.02%
----
----
----
----
----
Revenue
893.02%1.71M
42.12%1.46M
--0.00
--0.00
--172.00K
--1.03M
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
3168.33%1.96M
Operating profit
30.58%-8.34M
24.09%-8.54M
38.49%-7.26M
16.12%-10.51M
14.40%-12.01M
16.30%-11.24M
33.92%-11.80M
31.54%-12.52M
15.03%-14.03M
23.16%-13.43M
-9.26%-17.86M
-15.44%-18.29M
-19.85%-16.52M
-30.83%-17.48M
41.18%-16.34M
-201.39%-15.85M
-165.10%-13.78M
-170.27%-13.36M
-882.70%-27.78M
-55.10%-5.26M
Net Profit
3.18%-7.03M
-15.18%-10.30M
20.21%-5.41M
1.66%-6.69M
2.93%-7.26M
-26.05%-8.95M
26.25%-6.78M
26.85%-6.80M
10.62%-7.48M
19.21%-7.10M
-15.61%-9.20M
-22.02%-9.30M
-34.53%-8.37M
-69.32%-8.79M
-153.18%-7.96M
-39.00%-7.62M
-11.16%-6.22M
9.85%-5.19M
-8.98%-3.14M
-102.10%-5.49M
Current assets
164.81%47.09M
79.27%53.32M
-84.69%4.96M
-65.43%11.07M
-57.04%17.78M
-41.50%29.74M
-48.80%32.37M
-58.06%32.03M
-53.51%41.39M
-49.62%50.85M
-37.23%63.22M
-22.06%76.37M
-18.51%89.04M
-15.61%100.92M
-23.91%100.72M
41.04%97.99M
42.26%109.26M
--119.59M
--132.37M
--69.48M
Total current liabilities
-31.17%13.86M
-36.31%12.67M
-5.28%19.14M
24.38%20.62M
50.50%20.13M
148.98%19.89M
175.17%20.21M
189.12%16.58M
159.71%13.38M
65.92%7.99M
2.21%7.34M
7.22%5.74M
23.92%5.15M
82.39%4.81M
36.88%7.19M
-42.82%5.35M
-41.35%4.16M
--2.64M
--5.25M
--9.36M
Total assets
115.04%51.88M
60.02%58.62M
-76.71%10.14M
-61.35%16.90M
-54.92%24.13M
-36.75%36.63M
-38.19%43.54M
-47.64%43.73M
-44.52%53.51M
-46.39%57.92M
-34.90%70.44M
-19.97%83.51M
-16.36%96.45M
-13.03%108.03M
-21.00%108.20M
34.95%104.34M
40.49%115.31M
--124.21M
--136.96M
--77.32M
Total liabilities
-44.57%16.34M
-48.38%17.11M
-41.45%22.11M
-31.76%26.05M
-24.38%29.47M
2.06%33.14M
6.03%37.77M
8.03%38.18M
11.82%38.98M
-4.56%32.47M
64.93%35.62M
521.05%35.34M
647.20%34.86M
1188.75%34.02M
311.33%21.59M
-42.88%5.69M
-50.97%4.67M
--2.64M
--5.25M
--9.96M
Total equity
764.48%35.54M
1088.43%41.51M
-307.32%-11.97M
-264.92%-9.15M
-136.80%-5.35M
-86.27%3.49M
-83.41%5.78M
-88.48%5.55M
-76.40%14.54M
-65.62%25.44M
-59.80%34.82M
-51.17%48.17M
-44.34%61.59M
-39.12%74.00M
-34.24%86.61M
46.46%98.65M
52.48%110.64M
--121.57M
--131.71M
--67.36M
Net operating income
20.27%-6.50M
103.40%294.00K
39.80%-5.06M
35.81%-5.80M
13.33%-8.15M
30.64%-8.65M
41.20%-8.41M
26.60%-9.03M
22.64%-9.40M
14.70%-12.48M
-17.26%-14.30M
-19.10%-12.30M
-29.85%-12.15M
-27.78%-14.63M
-9.69%-12.20M
-83.51%-10.33M
-131.23%-9.36M
-70.88%-11.45M
-1759.70%-11.12M
-100.43%-5.63M
Net investment
-113.44%-2.45M
-1328.56%-30.97M
-100.00%0.00
-12.44%5.71M
77.08%18.23M
-81.01%2.52M
-95.98%469.00K
727.00%6.53M
149.67%10.29M
3004.60%13.27M
116.36%11.67M
308.18%789.00K
1723.23%4.12M
-68.63%-457.00K
---71.35M
-178.68%-379.00K
-156.57%-254.00K
-5.86%-271.00K
--0.00
-209.09%-136.00K
Net financing
99.28%-27.00K
698.22%44.85M
-113.10%-1.01M
33.33%188.00K
-3183.47%-3.73M
5753.13%5.62M
15622.45%7.70M
76.25%141.00K
1412.50%121.00K
-99.35%96.00K
-99.65%49.00K
63.27%80.00K
--8.00K
2709.47%14.87M
-80.32%14.08M
103.09%49.00K
-100.00%0.00
-100.83%-570.00K
2472.78%71.55M
-226.32%-1.58M

FAQs

What is the total revenue of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its total revenue reached 1.63M, with a year-on-year change of 1.03M.

What are the current assets of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its current assets were 53.32M, with a year-on-year change of 79.27.

What are the total assets of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its total assets of Rani Therapeutics Holdings Inc were 58.62M, with a year-on-year change of 60.02.

What are the total liabilities of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its total liabilities of Rani Therapeutics Holdings Inc were 17.11M, with a year-on-year change of -48.38.

What is the total equity of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its total equity of Rani Therapeutics Holdings Inc was 41.51M, with a year-on-year change of 1088.43.

What is the net operating income of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net operating income of Rani Therapeutics Holdings Inc was -38.31M, with a year-on-year change of 22.76.

What is the net investment of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net investment of Rani Therapeutics Holdings Inc was -7.03M, with a year-on-year change of -135.49.

What is the net financing of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net financing of Rani Therapeutics Holdings Inc was 40.30M, with a year-on-year change of 196.65.

What is the Earnings Per Share (EPS) of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.45, with a year-on-year change of 57.44.

What is the net income of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net income was -29.67M, with a year-on-year change of 1.15.

What is the net margin of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net profit margin was -2507.65, with a year-on-year change of 54.44.

What is the Return on Equity (ROE) of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -169.55, with a year-on-year change of 58.04.

What is the Return on Assets (ROA) of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -85.98, with a year-on-year change of 28.17.

What is the operating profit of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its operating profit was -38.31M, with a year-on-year change of 22.76.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.